SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)

32 participants · First posted Mar 10, 2010

Genetics of Familial and Sporadic ALS

13,521 participants · First posted Jan 13, 2009

Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders

6,000 participants · First posted Oct 25, 2011

ALS-2158

familial hypercholesterolemia program

ALS-002200

The Familial Hypercholesterolemia Foundation

United States

Target ALS Foundation, Inc.

United States

ALS Czech Republic, s.r.o.

Czech Republic

Ractigen Therapeutics Doses First Patient in Phase I Trial of RAG-17 for SOD1-Related ALS

International Experts to Convene at Les Turner ALS Symposium in Chicago

uniQure Doses First Patient in Phase I/II Trial of AMT-162 for SOD1-ALS